Jana Medical issues prospectus to list 642,500 shares on Nomu

17/10/2024 Argaam
Logo ofJana Medical Co.

Logo of Jana Medical Co. 


Jana Medical Co. issued today, Oct. 17, the prospectus to list 642,500 shares on Nomu-Parallel Market.


The offered shares represent 20% of post-IPO capital and 25% of pre-IPO capital amounting to SAR 25.7 million.

 

For More IPOs

 
The company's post-IPO capital will amount to SAR 32.12 million, divided into 3.21 million shares at SAR 10 each.


The share sale will run for nine working days from Nov. 06-14, 2024.

The share sale will be limited to qualified investors on Nomu-Parallel Market.

The Capital Market Authority (CMA) approved, on June 12, the company's application to float its shares on Nomu.


Jana Medical's actual activity is represented in the import and supply of medical equipment for public and private hospitals inside the Kingdom. It also has a number of medical agencies.

 

Company Profile 

Company 

Jana Medical Co.

Market 

Nomu Parallel Market

Core Activities 

Import and supply of medical devices, equipment and supplies

Pre-IPO Capital

SAR 25.7 mln

Number of shares 

2.57 mln shares

Post-IPO Capital

SAR 32.13 mln

Number of shares after IPO

3.21 mln

Share Par Value 

SAR 10/share

 

Company Shareholders

Shareholders

Before IPO

After IPO

Number of Shares

(‘000 shares)

Ownership (%)

Number of Shares

(mln shares)

Ownership (%)

Jana Investment Holding Co.

412.7

16.06%

412.7

12.85%

Eid Sultan Alotaibi

360.3

14.02%

360.3

11.21%

Meteb Sultan Alotaibi

8.9

0.35%

8.9

0.28%

Other shareholders owning less than 5% (7 shareholders)

238.9

9.29%

238.9

7.44%

The public owning less than 5% (814 shareholders)

1549.2

60.28%

1549.2

48.22%

The public (QFIs)

--

--

642.5

20.00%

Total

2570

100%

3212.5

100%

 

IPO Summary

Issue Percentage

25% of pre-IPO capital

20% of post-IPO capital

Offered shares

642,500 shares

IPO Minimum Limit

10 shares

IPO Maximum Limit

157,400 shares

Offer period

From Nov. 6-14, 2024

Final Allocation

Nov. 19, 2024

Refund (if any)

Nov. 24, 2024

   

Additional Information

Financial Advisor

Afaq Capital

Lead Manager

Musharaka Capital

Receiving Banks

Alistithmar Capital, Alinma Investment, SNB Capital, Aljazira Capital, Riyad Capital, ANB Capital, Albilad Capital, Al Rajhi Capital, Derayah Financial, Saudi Fransi Capital, SAB Invest, Alkhabeer Capital, Yaqeen Capital

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.